Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct

Alexander Rouch, Lúcia H. Kudo, Connie Hébert

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The purpose of this study was to determine whether the selective alpha- 2 agonist dexmedetomidine inhibits basic transport properties in the rat cortical collecting duct (CCD). Sprague-Dawley rat CCDs were isolated and perfused to allow measurement of osmotic water permeability (P(f)), transepithelial voltage (V(t)) and resistance (R(t)). Arginine vasopressin (AVP) increases P(f), hyperpolarizes V(t) and decreases R(t) in the CCD via stimulation of adenylyl cyclase. Dexmedetomidine at 100 nM added to the basolateral side of the CCD reduced AVP-stimulated P(f) by 95% to 100%, and the alpha-2 antagonist atipamezole reversed the inhibition. In the presence of the protein kinase C inhibitor staurosporine, dexmedetomidine reduced AVP- stimulated P(f) by 70% to 75% compared with the complete inhibition without staurosporine. When P(f) was increased by the use of the nonhydrolyzable analog of cAMP, 8-chlorophenylthio-cAMP, in lieu of AVP, dexmedetomidine inhibited P(f) by ~35%. This demonstrated alpha-2-mediated inhibition of P(f) despite the presence of constant cellular cAMP levels. Dexmedetomidine reversed AVP-induced effects on V(t) and R(t), indicating inhibition of Na+ transport. Results confirm an alpha-2-mediated mechanism that reduces Na+ and water transport in the CCD and suggest that a cellular messenger other than cAMP is involved. This messenger could be protein kinase C.

Original languageEnglish
Pages (from-to)62-69
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume281
Issue number1
StatePublished - 24 May 1997

Fingerprint

Dexmedetomidine
Arginine Vasopressin
Permeability
Water
Staurosporine
Protein Kinase C
Protein C Inhibitor
Protein Kinase Inhibitors
Adenylyl Cyclases
Sprague Dawley Rats

Cite this

@article{048794ac59f3425781f6a759bf05e743,
title = "Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct",
abstract = "The purpose of this study was to determine whether the selective alpha- 2 agonist dexmedetomidine inhibits basic transport properties in the rat cortical collecting duct (CCD). Sprague-Dawley rat CCDs were isolated and perfused to allow measurement of osmotic water permeability (P(f)), transepithelial voltage (V(t)) and resistance (R(t)). Arginine vasopressin (AVP) increases P(f), hyperpolarizes V(t) and decreases R(t) in the CCD via stimulation of adenylyl cyclase. Dexmedetomidine at 100 nM added to the basolateral side of the CCD reduced AVP-stimulated P(f) by 95{\%} to 100{\%}, and the alpha-2 antagonist atipamezole reversed the inhibition. In the presence of the protein kinase C inhibitor staurosporine, dexmedetomidine reduced AVP- stimulated P(f) by 70{\%} to 75{\%} compared with the complete inhibition without staurosporine. When P(f) was increased by the use of the nonhydrolyzable analog of cAMP, 8-chlorophenylthio-cAMP, in lieu of AVP, dexmedetomidine inhibited P(f) by ~35{\%}. This demonstrated alpha-2-mediated inhibition of P(f) despite the presence of constant cellular cAMP levels. Dexmedetomidine reversed AVP-induced effects on V(t) and R(t), indicating inhibition of Na+ transport. Results confirm an alpha-2-mediated mechanism that reduces Na+ and water transport in the CCD and suggest that a cellular messenger other than cAMP is involved. This messenger could be protein kinase C.",
author = "Alexander Rouch and Kudo, {L{\'u}cia H.} and Connie H{\'e}bert",
year = "1997",
month = "5",
day = "24",
language = "English",
volume = "281",
pages = "62--69",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct. / Rouch, Alexander; Kudo, Lúcia H.; Hébert, Connie.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 281, No. 1, 24.05.1997, p. 62-69.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct

AU - Rouch, Alexander

AU - Kudo, Lúcia H.

AU - Hébert, Connie

PY - 1997/5/24

Y1 - 1997/5/24

N2 - The purpose of this study was to determine whether the selective alpha- 2 agonist dexmedetomidine inhibits basic transport properties in the rat cortical collecting duct (CCD). Sprague-Dawley rat CCDs were isolated and perfused to allow measurement of osmotic water permeability (P(f)), transepithelial voltage (V(t)) and resistance (R(t)). Arginine vasopressin (AVP) increases P(f), hyperpolarizes V(t) and decreases R(t) in the CCD via stimulation of adenylyl cyclase. Dexmedetomidine at 100 nM added to the basolateral side of the CCD reduced AVP-stimulated P(f) by 95% to 100%, and the alpha-2 antagonist atipamezole reversed the inhibition. In the presence of the protein kinase C inhibitor staurosporine, dexmedetomidine reduced AVP- stimulated P(f) by 70% to 75% compared with the complete inhibition without staurosporine. When P(f) was increased by the use of the nonhydrolyzable analog of cAMP, 8-chlorophenylthio-cAMP, in lieu of AVP, dexmedetomidine inhibited P(f) by ~35%. This demonstrated alpha-2-mediated inhibition of P(f) despite the presence of constant cellular cAMP levels. Dexmedetomidine reversed AVP-induced effects on V(t) and R(t), indicating inhibition of Na+ transport. Results confirm an alpha-2-mediated mechanism that reduces Na+ and water transport in the CCD and suggest that a cellular messenger other than cAMP is involved. This messenger could be protein kinase C.

AB - The purpose of this study was to determine whether the selective alpha- 2 agonist dexmedetomidine inhibits basic transport properties in the rat cortical collecting duct (CCD). Sprague-Dawley rat CCDs were isolated and perfused to allow measurement of osmotic water permeability (P(f)), transepithelial voltage (V(t)) and resistance (R(t)). Arginine vasopressin (AVP) increases P(f), hyperpolarizes V(t) and decreases R(t) in the CCD via stimulation of adenylyl cyclase. Dexmedetomidine at 100 nM added to the basolateral side of the CCD reduced AVP-stimulated P(f) by 95% to 100%, and the alpha-2 antagonist atipamezole reversed the inhibition. In the presence of the protein kinase C inhibitor staurosporine, dexmedetomidine reduced AVP- stimulated P(f) by 70% to 75% compared with the complete inhibition without staurosporine. When P(f) was increased by the use of the nonhydrolyzable analog of cAMP, 8-chlorophenylthio-cAMP, in lieu of AVP, dexmedetomidine inhibited P(f) by ~35%. This demonstrated alpha-2-mediated inhibition of P(f) despite the presence of constant cellular cAMP levels. Dexmedetomidine reversed AVP-induced effects on V(t) and R(t), indicating inhibition of Na+ transport. Results confirm an alpha-2-mediated mechanism that reduces Na+ and water transport in the CCD and suggest that a cellular messenger other than cAMP is involved. This messenger could be protein kinase C.

UR - http://www.scopus.com/inward/record.url?scp=0030923072&partnerID=8YFLogxK

M3 - Article

C2 - 9103481

AN - SCOPUS:0030923072

VL - 281

SP - 62

EP - 69

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -